Generic drugmaker Teva bids $40 billion for rival Mylan

TEL AVIV/NEW YORK - Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying smaller rival Mylan for $40 billion, saying it was a better deal than Mylan's alternate offer to buy Perrigo Co.

Recent Business News

U.S. regulator wants better deposit data from big banks

WASHINGTON - The largest U.S. and foreign banks would need to keep track of deposits better under a plan launched by the Federal Deposit Insurance Corporation on Tuesday, as many lenders have grown and become more complex.

DuPont says strong dollar to have bigger impact than expected

- Chemical maker DuPont reported lower sales in all of its businesses and said a strong dollar would take a bigger toll on its full-year earnings than it had expected.

8:04am EDT

BlackBerry to buy WatchDox to bolster data security

TORONTO - BlackBerry Ltd said on Tuesday it is acquiring privately-held U.S. tech company WatchDox, which makes software that secures files, in a bid to further bolster its security credentials.

Tech, Deals 9:32am EDT

Safran faces AGM heat as revolt over French Florange law widens

PARIS - Proxy advisory firms are threatening to block key financial resolutions at French aerospace group Safran , opening a second front in a battle between the French government and institutional investors over a new corporate law.

Wary of brinkmanship, euro zone won't set more deadlines for Greece: official

WASHINGTON - Euro zone finance ministers will not be setting any deadlines for Greece because they lead to brinkmanship in negotiations on what reforms Athens needs to do in exchange for more funding, a senior euro zone official said on Tuesday.

10:33am EDT


  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary